# Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis

Study · id `cardio:ct-nct02657707` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02657707](<https://clinicaltrials.gov/study/NCT02657707>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02657707

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 295 participants.

## Technical summary

Registry record NCT02657707. Allocation not applicable; no masking; primary purpose treatment. Start 2016-04-21 (actual); primary completion 2022-04-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 295 participants (planned count; ClinicalTrials.gov record NCT02657707, source copy `cardio:ctgov-nct02657707-2023-02-28`, retrieved 2026-10-31)
- Started: 2016-04-21 (actual) (ClinicalTrials.gov record NCT02657707, source copy `cardio:ctgov-nct02657707-2023-02-28`, retrieved 2026-10-31)
- Primary completion: 2022-04-08 (actual) (ClinicalTrials.gov record NCT02657707, source copy `cardio:ctgov-nct02657707-2023-02-28`, retrieved 2026-10-31)
- Completion: 2024-05 (anticipated) (ClinicalTrials.gov record NCT02657707, source copy `cardio:ctgov-nct02657707-2023-02-28`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT02657707, source copy `cardio:ctgov-nct02657707-2023-02-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02657707-2023-02-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
- Condition: Carotid Artery Stenosis
- Intervention (Device): Roadsaver™ Carotid Artery Stent Device
- Intervention (Device): Nanoparasol® Embolic Protection System
- Lead sponsor: Microvention-Terumo, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Carotid artery stenosis (`cardio:carotid-stenosis`)
- Registry lists this organization as the lead sponsor: Microvention-Terumo, Inc. (`cardio:org-microvention-terumo-inc`)

## Provenance

Content hash: 38eac897f9e42d46d74fd32fb0917df226e09b7789030513ffa72bdcbd2911d8
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
